text: SECTION 1. SHORT TITLE.
  
      This Act may be cited as the ``Accelerating Biomedical Research 
  Act''.
  
  SEC. 2. FINDINGS.
  
      Congress makes the following findings:
              (1) The National Institutes of Health (referred to in this 
          section as the ``NIH'') is the leading biomedical research 
          entity in the world. It supports researchers in every State as 
          they discover treatments and cures to prevent and reduce human 
          suffering. Thanks in large part to NIH-funded medical research, 
          Americans today are living longer and healthier. Life 
          expectancy in the United States has jumped from 47 years in 
          1900 to 78 years in 2009, and disability in people over age 65 
          has dropped dramatically in the past 3 decades.
              (2) Over the past 40 years, NIH-supported research 
          contributed to the discovery of 153 new Food and Drug 
          Administration-approved drugs, vaccines, or new indications for 
          current drugs.
              (3) The application success rate is now at an all-time low. 
          From 1980 to 2003, the last year of the doubling, the grant 
          application success rate ranged between 25 and 35 percent. By 
          2013, the grant success rate had fallen to 16.8 percent.
              (4) Recent Federal funding cuts threaten to diminish United 
          States leadership in the world. The international community has 
          recognized the role biomedical research plays in generating 
          economic growth. England, China, Brazil, South Korea, India, 
          Singapore, Germany, France and Japan are increasing their 
          investment, despite the worldwide recession. Only the United 
          States has decreased its investment, from 0.215 percent of 
          Gross Domestic Product in 2003 (the last year of the doubling) 
          to 0.174 percent in 2013. In 8 years, if current trends 
          continue, China will surpass the United States in total 
          government biomedical research investment.
              (5) NIH is vital to the United States economy. In fiscal 
          year 2012, the NIH extramural program supported around 50,000 
          competitive research grants and 300,000 scientists and research 
          personnel at more than 2,500 universities, medical schools, and 
          other research institutions across our 50 States.
              (6) Economists have estimated the return on each dollar of 
          investment in NIH to generate anywhere from $1.80 to $3.20 in 
          economic output. The Federal investment of $3,800,000,000 in 
          the Human Genome Project from 1988 to 2003 helped drive 
          $796,000,000,000 in economic output, which is a return of $141 
          for every $1 invested.
              (7) In 2013, sales of products built around licensed NIH 
          and Food and Drug Administration inventions included 358 
          licensees reporting a total of $7,000,000,000 in sales.
              (8) The historic doubling of Federal funding for the 
          National Institutes of Health ended in fiscal year 2003. Since 
          that time, NIH appropriations have not kept up with biomedical 
          inflation. NIH has lost more than 20 percent of its purchasing 
          power for medical research since 2003.
              (9) If NIH had kept up with biomedical inflation, NIH's 
          appropriation would have totaled $37,000,000,000 in 2013, 
          instead of the $28,900,000,000 that was actually appropriated, 
          a loss of $8,100,000,000 or 28 percent. To restore funding to 
          the 2003 post-doubling level would require Congress to 
          appropriate $46,500,000,000 in fiscal year 2021, the final year 
          of the Budget Control Act of 2011 (Public Law 112-25).
              (10) High health care costs from a variety of common 
          conditions threaten Federal, State, and local budgets, as well 
          as the budgets of American families. Recent estimates indicate 
          that the economic costs of Alzheimer's disease is over 
          $200,000,000,000 each year but will rise to over 
          $1,000,000,000,000 by 2050 unless a prevention or cure is 
          found. In 2006, economists found that a future 1 percent 
          reduction in mortality rates from cancer would save 
          $500,000,000,000 to current and future Americans. A cure for 
          cancer was estimated to save $50,000,000,000,000 to Americans, 
          more than 3 times the gross domestic product of the United 
          States in 2012. The Centers for Disease Control and Prevention 
          reports that annual costs from undiagnosed diabetes was 
          $245,000,000,000 each year. And a recent study projects that by 
          2030, nearly 44 percent of the United States population will 
          face some form of cardiovascular disease costing a total of 
          $1,208,000,000,000 between 2012 and 2030.
              (11) Budget cap adjustments are how Congress traditionally 
          prioritizes areas of spending that produce economic growth and 
          reduce costs that contribute to the Federal debt.
  
  SEC. 3. CAP ADJUSTMENT.
  
      Section 251(b)(2) of the Balanced Budget and Emergency Deficit 
  Control Act of 1985 (2 U.S.C. 901(b)(2)) is amended--
              (1) by redesignating subparagraph (D) as subparagraph (E); 
          and
              (2) by inserting after subparagraph (C), the following:
                      ``(D) National institutes of health.--
                              ``(i) In general.--If a bill or joint 
                          resolution making appropriations for a fiscal 
                          year is enacted that specifies amounts for the 
                          National Institutes of Health at the Department 
                          of Health and Human Services (75-9915-1-1-552), 
                          then the adjustments for that fiscal year shall 
                          be the amount of additional new budget 
                          authority provided in that Act for such 
                          programs for that fiscal year, but shall not 
                          exceed--
                                      ``(I) for fiscal year 2015, 
                                  $3,000,000,000 in additional new budget 
                                  authority;
                                      ``(II) for fiscal year 2016, 
                                  $6,300,000,000 in additional new budget 
                                  authority;
                                      ``(III) for fiscal year 2017, 
                                  $8,100,000,000 in additional new budget 
                                  authority;
                                      ``(IV) for fiscal year 2018, 
                                  $10,000,000,000 in additional new 
                                  budget authority;
                                      ``(V) for fiscal year 2019, 
                                  $12,000,000,000 in additional new 
                                  budget authority;
                                      ``(VI) for fiscal year 2020, 
                                  $14,100,000,000 in additional new 
                                  budget authority; and
                                      ``(VII) for fiscal year 2021, 
                                  $16,300,000,000 in additional new 
                                  budget authority.
                              ``(ii) Definitions.--As used in this 
                          subparagraph:
                                      ``(I) Additional new budget 
                                  authority.--The term `additional new 
                                  budget authority' means the amount 
                                  provided for a fiscal year, in excess 
                                  of $29,926,104,000, in an appropriation 
                                  Act and specified to support the 
                                  National Institutes of Health.
                                      ``(II) National institutes of 
                                  health.--The term `National Institutes 
                                  of Health' means the appropriations 
                                  accounts that support the various 
                                  institutes, offices, and centers that 
                                  make up the National Institutes of 
                                  Health.''.
target: Accelerating Biomedical Research Act - Amends the Balanced Budget and Emergency Deficit Control Act of 1985 to require certain adjustments to discretionary spending limits in FY2015-FY2021 to accommodate increases in appropriations to the National Institutes of Health (NIH) at the Department of Health and Human Services (HHS).
feat_title: Accelerating Biomedical Research Act